Abstract
Therapeutic manipulation of gut microbiota has proven valuable in the management of ulcerative colitis and pouchitis. Despite some similarities among the various inflammatory bowel conditions, the probiotics investigated thus far seem to confer little benefit in Crohn's disease. In this review, we aim to bring together the evidence available on the clinical effect of probiotics and prebioltics in Crohn's disease patients, and to clarify the place of probiotic treatment in current Crohn's therapeutic regimens.
| Original language | English |
|---|---|
| Pages (from-to) | 81-88 |
| Number of pages | 8 |
| Journal | Best Practice and Research: Clinical Gastroenterology |
| Volume | 30 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Feb 2016 |
| Externally published | Yes |
Keywords
- Bifidobacterium
- Crohn's disease
- Inflammatory bowel disease
- Lactobacillus
- Prebiotics
- Probiotics
- Sacchromyces boullardi
- Synbiotics
- VSL#3
ASJC Scopus subject areas
- Gastroenterology
Fingerprint
Dive into the research topics of 'Probiotics and prebiotics in Crohn's disease therapies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver